BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 22044717)

  • 1. Initial survival data of kidney transplant patients with pre-transplant monoclonal gammopathy.
    Soltero L; Carbajal H; Xu J; McCarthy J; Suki WN; Gaber AO; Adrogué HE
    Clin Transplant; 2012; 26(2):300-4. PubMed ID: 22044717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term follow-up of patients with monoclonal gammopathy of undetermined significance after kidney transplantation.
    Naina HV; Harris S; Dispenzieri A; Cosio FG; Habermann TM; Stegall MD; Dean PG; Prieto M; Kyle RA; Rajkumar SV; Leung N
    Am J Nephrol; 2012; 35(4):365-71. PubMed ID: 22473253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monoclonal Gammopathy of Undetermined Significance After Kidney Transplantation: Single-Center Experience.
    Alfano G; Fontana F; Colaci E; Messerotti A; Bettelli F; Potenza L; Luppi M; Cappelli G
    Transplantation; 2017 Nov; 101(11):e337-e342. PubMed ID: 28731904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monoclonal gammopathy of undetermined significance does not affect outcomes in patients undergoing solid organ transplants.
    Jimenez-Zepeda VH; Heilman RL; Engel RA; Carey EJ; Freeman C; Rakela J; Mulligan DC; Fonseca R; Stewart AK
    Transplantation; 2011 Sep; 92(5):570-4. PubMed ID: 21712755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Monoclonal gammopathy of undetermined significance--potential risk factor of multiple myeloma].
    Stelmach-Gołdyś A; Czarkowska-Paczek B
    Przegl Lek; 2012; 69(5):194-6. PubMed ID: 23050415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Monoclonal gammopathy of undetermined significance (MGUS) in Mexican mestizos: one institution's experience].
    Ruiz-Delgado GJ; Gómez Rangel JD
    Gac Med Mex; 2004; 140(4):375-9. PubMed ID: 15456147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monoclonal gammopathy of unknown significance in kidney transplanted patients: novel insights into long-term outcomes.
    Meuleman MS; Mouyabi S; Gueguen J; Vicca S; Divard G; Aubert O; Bienaimé F; Arnulf B; Anglicheau D; Bridoux F; Cohen C
    Nephrol Dial Transplant; 2023 Dec; 39(1):64-73. PubMed ID: 37403344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Monoclonal gammopathy of undetermined significance].
    Chaïbi P; Merlin L; Thomas C; Piette F
    Ann Med Interne (Paris); 2002 Nov; 153(7):459-66. PubMed ID: 12598832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relationship between monoclonal gammopathy of undetermined significance and venous thromboembolic disease.
    Cohen AL; Sarid R
    Thromb Res; 2010 Mar; 125(3):216-9. PubMed ID: 19193398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Follow-up monoclonal gammopathy of undetermined significance in kidney transplant.
    Cuéllar-García C; Sevillano Ruiz-Mateos C; Mazuecos Blanca MA; Narvaez Mejia C; Fernandez Valle MC; Martin Reina V; Gonzalez Bernal M; Yera Cobo M; Rodriguez Lopez R; de Cos Hohr C; Garrastazul MP; Marchante I; Paz Coll A; Capote Huelva FJ
    Transplant Proc; 2015; 47(1):78-80. PubMed ID: 25645776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence and evolution of monoclonal gammopathy of undetermined significance (MGUS) in Greece.
    Anagnostopoulos A; Evangelopoulou A; Sotou D; Gika D; Mitsibounas D; Dimopoulos MA
    Ann Hematol; 2002 Jul; 81(7):357-61. PubMed ID: 12185503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neoplastic and non-neoplastic complications of solid organ transplantation in patients with preexisting monoclonal gammopathy of undetermined significance.
    Goebel TE; Schiltz NK; Woodside KJ; Pillai AC; Caimi PF; Lazarus HM; Koroukian SM; Campagnaro EL
    Clin Transplant; 2015 Sep; 29(9):851-7. PubMed ID: 26194021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monoclonal gammopathy of undeterminated significance: introduction and current clinical issues.
    Klincová M; Sandecká V; Mikuláiová A; Radocha J; Maisnar V; Hájek R
    Klin Onkol; 2011; 24 Suppl():S14-7. PubMed ID: 21923058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Benign monoclonal gammopathy].
    Shirota T; Kondo M; Uchida H; Ito H
    Nihon Rinsho; 1995 Mar; 53(3):720-4. PubMed ID: 7699912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes of Monoclonal Gammopathy of Undetermined Significance in Patients Who Underwent Kidney Transplantation.
    Bancu I; Cañas L; Juega FJ; Pérez M; Malumbres S; Bonet J; Lauzurica R
    Transplant Proc; 2015 Oct; 47(8):2344-5. PubMed ID: 26518922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monoclonal gammopathy of undetermined significance (MGUS) is associated with an increased frequency of Epstein-Barr Virus (EBV) latently infected B lymphocytes in long-term renal transplant patients.
    Babel N; Schwarzmann F; Pruss A; Volk HD; Reinke P
    Transplant Proc; 2004 Nov; 36(9):2679-82. PubMed ID: 15621122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monoclonal gammopathy of undetermined significance and smoldering multiple myeloma.
    Kyle RA; Rajkumar SV
    Hematol Oncol Clin North Am; 2007 Dec; 21(6):1093-113, ix. PubMed ID: 17996590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monoclonal gammopathies of undetermined significance.
    Kyle RA; Rajkumar SV
    Best Pract Res Clin Haematol; 2005; 18(4):689-707. PubMed ID: 16026745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigation of monoclonal gammopathy of undetermined significance: a single-centre study.
    Simon Z; Sipka S; Gergely L; Csípö I; Illés A
    Clin Lab Haematol; 2006 Jun; 28(3):164-9. PubMed ID: 16706932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Multiple myeloma after monoclonal gammopathy of uncertain significance. Study of 10 patients].
    Salgado C; Bladé J; López-Guillermo A; Cervantes F; Montserrat E; Rozman C
    Sangre (Barc); 1993 Oct; 38(5):371-4. PubMed ID: 8140498
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.